126 results
10-K
2017 FY
EX-2.3
SLDB
Solid Biosciences Inc
29 Mar 18
Annual report
12:00am
, on account of the gross negligence, intentional misrepresentation, willful misconduct or fraud of the Company in connection with the execution of the Merger … negligence, intentional misrepresentation, willful misconduct or fraud of the Bain Funds or the Bain Blocker, and (iii) any and all Damages arising
10-K
2017 FY
EX-31.2
SLDB
Solid Biosciences Inc
29 Mar 18
Annual report
12:00am
ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other
8-K
EX-99.2
m1tw1e
5 Dec 22
Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
7:48am
10-Q
EX-31.2
3cdeotdb8m36puzunhr
10 May 18
Quarterly report
7:42am
10-Q
EX-31.1
nq8tcs
10 May 18
Quarterly report
7:42am